<p>Here we consider a baseline mutation rate per cell division of 10<sup>−8</sup> and the effect of drug concentration on the mutation rate <i>β</i> = 10<sup>−9</sup>. (A) The drug concentration <i>in vivo</i> based on the pharmacokinetic model over time for a 100mg per day continuous dosing regime. Dotted line: loading dose; solid line: no loading dose. (B) The birth rates as a function of time <i>t</i>. Red line: the birth rate of the resistant cells; black line: the birth rate of the sensitive cells. (C) The mutation rate of sensitive cells as a function of time <i>t</i>. Blue line: constant mutation rate; green line: mutation rate monotonically decreases with the drug concentration; black line: mutation rate monotonically increases with...
<p>(A–C) Numerical solution of the model equations showing the time evolution of healthy (blue line)...
<p>(A) This tracking plot shows that the expression of the activator increases while the antibiotic ...
© 2015 Chevereau et al.The emergence of drug resistant pathogens is a serious public health problem....
<p>Here we consider <i>β</i> = 10<sup>−10</sup>. (A) The dosing regimes with no loading dose for 100...
<p>(A) Expected number of resistant cancer cells as a function of time during continuous therapy. Bl...
<p>Here we consider <i>β</i> = 10<sup>−10</sup>. (A)–(C): (A) The area under the curve (AUC) of the ...
<p>(A), (B) and (C) are examples for sine wave functional forms of birth, death and mutation rates. ...
<p>We developed a mathematical model to investigate the effects of changing mutation rates during tr...
<p>(A) Simulation results from a theoretical model of resistance evolution in a morbidostat [<a href...
<p>(<b>A</b>) Shown is the probability that no resistant cells are present at time <i>t</i>, conditi...
<p><b>(A)</b> The changes in the risk of <i>de novo</i> resistance, Φ<sub><i>m</i></sub>, generated ...
Anti-cancer drugs targeted to specific oncogenic pathways have shown promising therapeutic results i...
<p>Panel <b>a</b> considers the probability of pre-existing resistance versus the dedifferentiation ...
<p><b>(A)</b> A schematic illustrating how a non-preexisting mutant, A’B’, fully resistant to a comb...
<p>(A) The probability of developing resistance during continuous therapy as a function of the growt...
<p>(A–C) Numerical solution of the model equations showing the time evolution of healthy (blue line)...
<p>(A) This tracking plot shows that the expression of the activator increases while the antibiotic ...
© 2015 Chevereau et al.The emergence of drug resistant pathogens is a serious public health problem....
<p>Here we consider <i>β</i> = 10<sup>−10</sup>. (A) The dosing regimes with no loading dose for 100...
<p>(A) Expected number of resistant cancer cells as a function of time during continuous therapy. Bl...
<p>Here we consider <i>β</i> = 10<sup>−10</sup>. (A)–(C): (A) The area under the curve (AUC) of the ...
<p>(A), (B) and (C) are examples for sine wave functional forms of birth, death and mutation rates. ...
<p>We developed a mathematical model to investigate the effects of changing mutation rates during tr...
<p>(A) Simulation results from a theoretical model of resistance evolution in a morbidostat [<a href...
<p>(<b>A</b>) Shown is the probability that no resistant cells are present at time <i>t</i>, conditi...
<p><b>(A)</b> The changes in the risk of <i>de novo</i> resistance, Φ<sub><i>m</i></sub>, generated ...
Anti-cancer drugs targeted to specific oncogenic pathways have shown promising therapeutic results i...
<p>Panel <b>a</b> considers the probability of pre-existing resistance versus the dedifferentiation ...
<p><b>(A)</b> A schematic illustrating how a non-preexisting mutant, A’B’, fully resistant to a comb...
<p>(A) The probability of developing resistance during continuous therapy as a function of the growt...
<p>(A–C) Numerical solution of the model equations showing the time evolution of healthy (blue line)...
<p>(A) This tracking plot shows that the expression of the activator increases while the antibiotic ...
© 2015 Chevereau et al.The emergence of drug resistant pathogens is a serious public health problem....